Article
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
Bone marrow transplantation - 1 Dec 1999
McCarthy A J, Kingman H M, Kelly C, Taylor G S, Caul E O, Grier D, Moppett J, Foot A B, Cornish J M, Oakhill A, Steward C G, Pamphilon D H, Marks D I
Abstract excerpt
Respiratory syncytial virus (RSV) is known to cause acute lung injury in the immunocompromised host, especially recipients of bone marrow allografts. Specific prognostic factors for the development of severe life-threatening disease remain to be identified as does the optimum treatment of established disease. Over a 5-year period the incidence and outcome of RSV in BMT recipients was analysed retrospectively....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.